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This is a review of research carried out in Japanese Americans that points towards possible
approaches to prevention of type 2 diabetes mellitus. The natural history of type 2 diabetes
usually includes both insulin resistance and b-cell dysfunction. Insulin secretion may compen-
sate for insulin resistance. Alternatively, enhanced insulin sensitivity may mask an insulin
secretory defect. Epidemiological data support the view that in the vast majority of cases of type
2 diabetes, insulin resistance is essential to the pathogenesis of hyperglycemia. Increased
diabetes prevalence as ethnic groups migrate to more urban or westernized regions has been
attributed to increased occurrence of insulin resistance. Research among Japanese Americans in
Seattle, Washington, showed a higher prevalence of type 2 diabetes than in Japan, which
suggested that factors associated with `westernization' might be playing a role in bringing out
underlying susceptibility to diabetes. Our research has shown that these impressions were
correct and that the abnormalities that characterize the metabolic syndrome play a significant
role. Due to increased intra-abdominal fat deposition, Japanese Americans were likely to be
`metabolically obese' despite relatively normal BMI. A diet higher in animal fat and lower
levels of physical activity were risk factors leading to increased intra-abdominal fat deposition,
insulin resistance, and diabetes. Information from epidemiological studies such as these may be
used to determine whether diabetes may be prevented through changes in lifestyle or application
of specific therapies targeted towards identified metabolic abnormalities.
b-Cell dysfunction: Insulin resistance: Metabolic obesity: Westernization
World-wide diabetes prevalence rates suggest that increas-
ing westernization and urbanization are associated with
higher rates of diabetes (King et al. 1993, 1998). There are
many examples of this. One example are the Japanese in
the United States. In the early 1980s the prevalence of
diabetes among Nisei (second-generation Japanese Amer-
icans) in Seattle was four times the published rates from
Tokyo, under identical diagnostic criteria Ð 20 % in men
and 16 % in women in Seattle compared to 5 % and 4 % in
men and women, respectively in Tokyo (Fujimoto et al.
1994b). This observation strongly suggested that the
exposure of Japanese to an American life-style brought
out an inherent tendency to develop diabetes. The question
remained as to what factors were important and how this
came about. This review summarizes several key findings
of our research that address this question.
The major metabolic defects in type 2 diabetes
The diagnostic hallmark of diabetes is hyperglycemia,
demonstrated in either the fasting state or following
glucose. Although there is debate about whether the fasting
plasma glucose or the oral glucose tolerance test (OGTT)
are better for the diagnosis of diabetes, there is general
agreement that the pathogenesis of hyperglycemia can be
attributed to abnormalities in three areas (Kahn & Porte,
1997). These are the action of insulin upon peripheral
tissues such as muscle and fat, the ability of the pancreatic
islet b-cells to produce and secrete insulin, and the
regulation of hepatic glucose production. With diabetes
there is insulin resistance, pancreatic islet b-cell dysfunc-
tion, and hepatic glucose over-production.
The natural history of type 2 diabetes is characterized by
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transition from normal glucose tolerance to an intermediate
state of metabolic abnormality that has been called
`impaired glucose homeostasis' (The Expert Committee
on the Diagnosis and Classification of Diabetes Mellitus,
1997). Included in impaired glucose homeostasis are two
conditions, impaired fasting glucose and impaired glucose
tolerance. The former is diagnosed by a fasting plasma
glucose level from 6´1 to ,7´0 mM while the latter is
diagnosed by a 2 h plasma glucose level from 7´8 to
,11´1 mM during a 75 g oral glucose tolerance test.
Diabetes is diagnosed by a fasting plasma glucose
$7´0 mM and/or a 2 h plasma glucose $11´1 mM. Both
impaired glucose homeostasis and diabetes are accompa-
nied by varying degrees of abnormalities in insulin action,
insulin secretion, and hepatic glucose production.
Insulin resistance, obesity, and body fat distribution
To learn more about why diabetes was more prevalent in
Japanese Americans than in native Japanese in Tokyo,
Seattle Nisei and Tokyo Japanese men with diabetes who
were matched by age were compared (Fujimoto et al.
1989). During an oral glucose tolerance test, both groups
were similarly hyperglycemic. However, the Seattle men
had significantly higher fasting insulin levels as well as
insulin levels during a 75 g OGTT. These observations are
consistent with greater insulin resistance among the Seattle
men. In addition, the Seattle men had significantly higher
mean body mass index (BMI).
It is known that diabetes prevalence is related to obesity,
although the relationship differs by race and ethnicity. It is
also known that weight loss improves insulin sensitivity.
Thus the greater insulin resistance in Seattle men was
consistent with their being heavier than the Tokyo men. In
turn, the greater insulin resistance in Seattle men could be
responsible for the greater prevalence of diabetes in Nisei.
If the greater degree of insulin resistance in Seattle men
was due to their greater BMI, adjustment for BMI should
result in the insulin levels no longer being significantly
different. However, fasting insulin remained significantly
different between the Seattle and Tokyo men following
adjustment for BMI. This suggested that BMI differences
could not completely account for the greater insulin
resistance in the Seattle men.
It is clear that the pattern of body fat distribution is
significantly related to metabolic disease (Vague, 1956).
The android or abdominal pattern consists of greater
amounts of fat on and in the trunk while the gynoid or
lower body pattern is characterized by more peripheral fat,
particularly around the hips and thighs. The former pattern
is associated with greater metabolic risk. Hence this type of
body fat pattern represents `metabolic obesity'. Moreover,
the android pattern that is associated with intra-abdominal
or visceral fat is at the greatest risk for metabolic disease
(Matsuzawa et al. 1992). Intra-abdominal fat may be
measured by using either computed tomography (CT) or
magnetic resonance imaging.
When adipose variables were compared in Nisei men
with and without type 2 diabetes, intra-abdominal fat as
measured by CT was the only adipose measurement that
was associated with diabetes (Shuman et al. 1986). The
other adipose variables included BMI, skinfolds, and
circumferences. Men with low amounts of intra-abdominal
fat tended to have normal glucose tolerance while those
with high amounts tended to be diabetic.
Subsequent research showed that the insulin sensitivity
index of Bergman, Si, was significantly correlated with
intra-abdominal fat (Fujimoto et al. 1994a). Furthermore,
intra-abdominal fat correlated better than Si did with a
variety of metabolic variables that are associated with the
insulin resistance syndrome. Prospectively, intra-abdominal
fat was also shown to be a risk factor for the development
of diabetes (Bergstrom et al. 1990a).
b-Cell lesions of diabetes
Insulin resistance, however, is insufficient to cause hyper-
glycemia. This is exemplified by a study of insulin sensitivity
in persons with perfectly normal glucose tolerance (Berg-
man, 1989). Whereas white males were very insulin
sensitive, women in the third trimester of pregnancy were
extremely resistant to insulin. A study of the relationship
between insulin secretion and insulin action showed that in
persons with normal glucose tolerance, insulin secretion can
adequately compensate for insulin resistance. This suggests
that for diabetes to develop in persons who are insulin
resistant, b-cell function must be impaired.
It is clear that among persons with type 2 diabetes are
individuals who have low amounts of intra-abdominal fat
and who are thus presumably not very insulin resistant.
Such individuals are diabetic because they have a more
profound b-cell defect than diabetic persons with large
amounts of intra-abdominal fat.
The b-cell abnormalities associated with diabetes fall
into two main categories, altered stimulus-secretion
coupling of glucose as an insulin secretagogue and
abnormal processing of secretory proteins. As an example
of the former, during an oral glucose tolerance test,
individuals with impaired glucose tolerance and with
diabetes have delayed secretion of insulin (Bergstrom
et al. 1990b). This delay was seen at baseline in non-
diabetic Japanese Americans who subsequently developed
diabetes during a 5-year follow-up period (Chen et al.
1995). Thus abnormal stimulus-secretion coupling was
present in persons who were prediabetic.
An example of abnormal secretory protein processing is
demonstrated by higher proinsulin levels, expressed both as
concentration of proinsulin and as proinsulin as a
percentage of total immunoreactive insulin, in persons
with diabetes compared to those with normal glucose
tolerance (Kahn et al. 1995). Moreover, at baseline while
still non-diabetic, those Japanese Americans who subse-
quently were found to have diabetes had higher fasting
plasma levels of proinsulin than those who remained non-
diabetic. In other words, higher proinsulin was a marker for
prediabetes.
Interaction of insulin resistance and b-cell dysfunction
in the pathogenesis of type 2 diabetes
Both genetic and environmental factors interact to cause
insulin resistance. In response to insulin resistance, the
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normal b-cell hypersecretes insulin, resulting in hyper-
insulinemia. In contrast, the abnormal b-cell cannot fully
compensate, resulting in relative insulin deficiency and
hyperglycemia (Fig. 1).
Genes and environment also interact to cause impaired
b-cell function. As long as insulin sensitivity is retained,
however, glucose tolerance remains normal despite
hypoinsulinemia. If insulin resistance develops, hypergly-
cemia ensues because of insulin deficiency (Fig. 2).
The contributions of intra-abdominal fat, insulin resis-
tance, and impaired b-cell function to the development of
diabetes were examined in a group of 137 non-diabetic
Nisei men followed for 5 years (Chen et al. 1995). Thirteen
men had developed diabetes at 2.5 years and ten had
developed it at 5 years of follow-up. At baseline, the first
group had significantly increased intra-abdominal fat,
elevated fasting plasma C-peptide, and lower insulin
secretion at 30 min following oral glucose. The second
group also had significantly lower insulin secretion at
30 min following oral glucose at baseline, but no
significant difference in intra-abdominal fat or fasting C-
peptide levels. When this group developed diabetes at 5
years, however, an increase of intra-abdominal fat was
found superimposed upon the pre-existing lower insulin
response. Thus both insulin resistance and impaired b-cell
function contribute to the development of type 2 diabetes in
Japanese Americans, and impaired b-cell function may be
present earlier than visceral adiposity in some who
subsequently develop diabetes.
Life-style and diabetes
Both genetic and life-style factors are important in the
etiology of diabetes. Family history of diabetes is often
used to indicate genetic risk while physical activity (energy
expenditure) and dietary composition are used to assess
life-style. Among dietary factors, animal fat (saturated fat)
intake has been implicated as an important risk factor for
diabetes.
Persons with impaired glucose tolerance are at a greatly
increased risk of subsequently developing diabetes. They
therefore represent an important group for determining
antecedent risk factors for diabetes. Nisei men who had
impaired glucose tolerance were followed for 5 years, at
which time 75 g oral glucose tolerance tests were done and
2 h plasma glucose levels measured. The 5-year glucose
level was examined in terms of baseline mean energy
expenditure and animal fat intake and family history of
diabetes. This analysis showed that glucose levels at 5
years were significantly increased in men with a family
history of diabetes who were exercising less or eating more
animal fat than at baseline. Thus physical activity and diet
are indeed important risk factors and these interact with
genetic factors (Leonetti et al. 1996).
Diabetes risk in Japanese-American women
Baseline characteristics of Japanese-American women by
follow-up glucose tolerance status showed that those who
go on to develop diabetes were significantly older and had
significantly greater amounts of intra-abdominal fat. The
difference in intra-abdominal fat was greatly attenuated
when adjusted for age.
Sansei (third generation Japanese-American) have lower
diabetes rates than do Nisei. Sansei in our study cohort are
about 20 years younger than the Nisei so the lower diabetes
rates are expected. Nonetheless, there are age-related
gender differences that are quite striking. For example,
Sansei women have much lower cumulative incidence rates
for diabetes than do Sansei men. On the other hand, Nisei
women have similar or higher cumulative incidence rates
for diabetes as Nisei men. Thus the disparity between Nisei
and Sansei is much greater for women than men.
Since the distribution of body fat is a risk factor for
diabetes, we looked at this in women. By CT scan, Nisei
women had more intra-abdominal and thoracic subcuta-
neous fat and less thigh subcutaneous fat than did Sansei
women. The result is a more android pattern of body fat
distribution in Nisei women.
Several variables related to diabetes Ð glucose, c-
peptide, intra-abdominal fat, and BMI Ð were examined
by age in Japanese-American women. For all of these
except BMI, there was a significant increase with age,
consistent with a deteriorating glucose tolerance, increasing
insulin resistance, and more visceral adiposity. In addition,
however, there was a particularly notable increase in intra-
abdominal fat between the age groups 40±49 years and 50±
59 years. Since the average age of menopause is 51 years,
these results strongly suggest that Japanese-American
women may be relatively protected against diabetes until
after they pass through the menopause, and that the
increased risk seen following the menopause may be due
to increased visceral fat and increased insulin resistance.
Fig. 1. Insulin resistance as the primary abnormality Ð normogly-
cemia with hyperinsulinemia or hyperglycemia with relative insulin
deficiency.
Fig. 2. Pancreatic islet b-cell as the primary abnormality Ð
normoglycemia with hypoinsulinemia or hyperglycemia with insulin
deficiency.
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Implications for Japan
Studies in Japanese Americans therefore strongly suggest
that the superimposition of `metabolic obesity' with
concomitant insulin resistance has brought out an under-
lying decreased b-cell reserve, resulting in hyperglycemia
and diabetes. If this sequence is correct, we may anticipate
diabetes rates in Japan to increase as many western lifestyle
customs are adopted.
Recent diabetes prevalence data from Japan indicate
diabetes rates to be much higher than were present in the
early 1980s when we began our research (Fujimoto et al.
1994b). Based upon these latest data, it is probably safe to
estimate diabetes prevalence to be at least 10 % in Japan in
1990. Moreover, secular trends of nutrient intake in Japan
from 1955 to 1995 clearly show an increase in national
consumption of animal protein and animal fat (Kitagawa
et al. 1998). Thus the question is when will diabetes
prevalence reach the 20 % rate found in Seattle Nisei in
1983?
Conclusions
Epidemiological studies such as ours show associations that
suggest cause and effect. To prove the latter, however,
clinical trials are required. We can use the information from
epidemiological studies to develop interventions to prevent
diabetes.
Although there is no way to modify genetic factors, life-
style can be altered. These life-style changes Ð diet and
exercise Ð can be applied broadly or may be directed
towards individuals who are judged to be at increased risk
for diabetes as ascertained by information such as family
history of diabetes or physical findings such as central
obesity. Metabolic profiling may become a tool in the
future to identify persons who are at increased metabolic
risk for diabetes because of insulin resistance or diminished
b-cell function. This information may be useful in directing
therapies that appropriately address the identified metabolic
abnormalities.
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